216 related articles for article (PubMed ID: 24780061)
1. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
2. Association of Circulating 25-Hydroxyvitamin D Levels with Colorectal Cancer: An Updated Meta-Analysis.
Xu J; Yuan X; Tao J; Yu N; Wu R; Zhang Y
J Nutr Sci Vitaminol (Tokyo); 2018; 64(6):432-444. PubMed ID: 30606966
[TBL] [Abstract][Full Text] [Related]
3. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
4. Association between Blood 25-Hydroxyvitamin D Levels and Survival in Colorectal Cancer Patients: An Updated Systematic Review and Meta-Analysis.
Maalmi H; Walter V; Jansen L; Boakye D; Schöttker B; Hoffmeister M; Brenner H
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30011816
[TBL] [Abstract][Full Text] [Related]
5. Circulating 25-hydroxyvitamin D level and prognosis of lung cancer patients: A systematic review and meta-analysis.
Huang JD; Dong CH; Shao SW; Gu TJ; Hu ZL; Ying J; Zhou DF; Xie YP
Bull Cancer; 2017; 104(7-8):675-682. PubMed ID: 28587766
[TBL] [Abstract][Full Text] [Related]
6. Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Vrieling A; Seibold P; Johnson TS; Heinz J; Obi N; Kaaks R; Flesch-Janys D; Chang-Claude J
Int J Cancer; 2014 Jun; 134(12):2972-83. PubMed ID: 24272459
[TBL] [Abstract][Full Text] [Related]
7. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies.
Ma Y; Zhang P; Wang F; Yang J; Liu Z; Qin H
J Clin Oncol; 2011 Oct; 29(28):3775-82. PubMed ID: 21876081
[TBL] [Abstract][Full Text] [Related]
8. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
[TBL] [Abstract][Full Text] [Related]
9. Serum 25-hydroxyvitamin D levels and prognosis in hematological malignancies: a systematic review and meta-analysis.
Wang W; Li G; He X; Gao J; Wang R; Wang Y; Zhao W
Cell Physiol Biochem; 2015; 35(5):1999-2005. PubMed ID: 25871640
[TBL] [Abstract][Full Text] [Related]
10. The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.
Schmutz EA; Zimmermann MB; Rohrmann S
Eur J Nutr; 2016 Feb; 55(1):393-402. PubMed ID: 25701092
[TBL] [Abstract][Full Text] [Related]
11. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis.
Wu G; Xue M; Zhao Y; Han Y; Zhang S; Zhang J; Li C; Xu J
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32686830
[TBL] [Abstract][Full Text] [Related]
12. Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.
Yin L; Ordóñez-Mena JM; Chen T; Schöttker B; Arndt V; Brenner H
Prev Med; 2013 Dec; 57(6):753-64. PubMed ID: 24036014
[TBL] [Abstract][Full Text] [Related]
13. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Neuberg DS; Hollis BW; Wain JC; Lynch TJ; Giovannucci E; Su L; Christiani DC
J Clin Oncol; 2007 Feb; 25(5):479-85. PubMed ID: 17290055
[TBL] [Abstract][Full Text] [Related]
14. 25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival.
Kanstrup C; Teilum D; Rejnmark L; Bigaard JV; Eiken P; Kroman N; Tjønneland A; Mejdahl MK
Breast Cancer Res Treat; 2020 Feb; 179(3):699-708. PubMed ID: 31707511
[TBL] [Abstract][Full Text] [Related]
15. Circulating 25-hydroxyvitamin D concentration and cause-specific mortality in the Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Kvaskoff D; Eyles DW; Giles GG; English DR; Williamson EJ
J Steroid Biochem Mol Biol; 2020 Apr; 198():105612. PubMed ID: 32007563
[TBL] [Abstract][Full Text] [Related]
16. Dose-response of serum 25-hydroxyvitamin D in association with risk of colorectal cancer: A meta-analysis.
Garland CF; Gorham ED
J Steroid Biochem Mol Biol; 2017 Apr; 168():1-8. PubMed ID: 27993551
[TBL] [Abstract][Full Text] [Related]
17. Association between blood circulating vitamin D and colorectal cancer risk in Asian countries: a systematic review and dose-response meta-analysis.
Zhang L; Zou H; Zhao Y; Hu C; Atanda A; Qin X; Jia P; Jiang Y; Qi Z
BMJ Open; 2019 Dec; 9(12):e030513. PubMed ID: 31874870
[TBL] [Abstract][Full Text] [Related]
18. The association of circulating 25-hydroxyvitamin D concentration with peripheral arterial disease: A meta-analysis of observational studies.
Nsengiyumva V; Fernando ME; Moxon JV; Krishna SM; Pinchbeck J; Omer SM; Morris DR; Jones RE; Moran CS; Seto SW; Golledge J
Atherosclerosis; 2015 Dec; 243(2):645-51. PubMed ID: 26554715
[TBL] [Abstract][Full Text] [Related]
19. Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.
Weinstein SJ; Mondul AM; Yu K; Layne TM; Abnet CC; Freedman ND; Stolzenberg-Solomon RZ; Lim U; Gail MH; Albanes D
Eur J Epidemiol; 2018 Nov; 33(11):1087-1099. PubMed ID: 30073448
[TBL] [Abstract][Full Text] [Related]
20. Circulating 25-hydroxyvitamin D levels and prognosis among cancer patients: a systematic review.
Toriola AT; Nguyen N; Scheitler-Ring K; Colditz GA
Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):917-33. PubMed ID: 24692501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]